CHU de Nice
Nice, 06000, France
NCT Number: NCT01260792
Almost all rating scales for Attention-Deficit/Hyperactivity Disorder (ADHD) are not validated in France. This clearly hampers the development of the diagnosis and the monitoring of patients but also research in this domain. This study is conceived to collect data in the general population of children aged from 4 to 18 years in public schools in the city of Nice.
Children are pseudo-randomly selected from classes of randomly selected schools in the city of Nice (France). Teachers fill out questionnaires using a dedicated secured website, and ask parents to fill out a similar set of questionnaires regarding their child's behaviour at home. Since ADHD has a strong genetic components, parents are also asked to fill out questionnaires regarding their own behaviour at adulthood and in childhood retrospectively.
Additionally, known factors related to ADHD and other disorders as well as other putative factors are tested in the epidemiologic study.
Looking for future studies?
Notify Me5 year–18 year
All sexes
Observational
Nice, 06000, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The teachers or the professors complete questionnaires on the child on their behavior in classes
Time frame: at time=0
The only criterion of evaluation towards the type of the study and its main objective is Validity of the studied instruments
Centre Hospitalier Universitaire de Nice
Other
Validation and Norms for Attention Deficit/Hyperactivity Disorder Scales in Children and Adults. Description of Associated Factors.
Acronym: ChiP-ARD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05336604
General Population
Le Kremlin-Bicêtre, France
View Trial DetailsNCT05530720
General Population
Bamberg, Germany
View Trial DetailsNCT05403398
General Population
Ede, ZB, Netherlands
View Trial DetailsNCT04551638
General Population
Barcelona, Catalonia, Spain
View Trial Details